What does Dr. Vanderlinden Esther anatoom-patholoog do?

Dr. Vanderlinden Esther anatoom-patholoog is a specialist medical practice in Wemmel. Private Limited, started on 17 April 2015, 1 establishment.

What is the address of Dr. Vanderlinden Esther anatoom-patholoog?

The registered office of Dr. Vanderlinden Esther anatoom-patholoog is located at Holland 42, 1780 Wemmel.

Is Dr. Vanderlinden Esther anatoom-patholoog still active?

Yes. According to the CBE (16 September 2026) Dr. Vanderlinden Esther anatoom-patholoog is active, legal situation “Normale toestand”, started on 17 April 2015.

Is Dr. Vanderlinden Esther anatoom-patholoog registered on Peppol?

Yes, Dr. Vanderlinden Esther anatoom-patholoog is registered on the Peppol network with ID 0208:0628697778.

What is the enterprise number of Dr. Vanderlinden Esther anatoom-patholoog?

The enterprise number of Dr. Vanderlinden Esther anatoom-patholoog is BE0628697778.

When was Dr. Vanderlinden Esther anatoom-patholoog founded?

Dr. Vanderlinden Esther anatoom-patholoog was founded on 17 April 2015.

Who are the directors of Dr. Vanderlinden Esther anatoom-patholoog?

According to the 2025 annual accounts, the directors of Dr. Vanderlinden Esther anatoom-patholoog are: Esther Vanderlinden.

Is Dr. Vanderlinden Esther anatoom-patholoog a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 April 2015; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Vanderlinden Esther anatoom-patholoog make in 2025?

Dr. Vanderlinden Esther anatoom-patholoog posted a profit after taxes of € 45,423 in financial year 2025.

What is the revenue of Dr. Vanderlinden Esther anatoom-patholoog?

As a small company, Dr. Vanderlinden Esther anatoom-patholoog is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 65,135.

Dr. Vanderlinden Esther anatoom-patholoog (Private Limited)

Dossier Dr. Vanderlinden Esther anatoom-patholoog, printed on 16 September 2026 from databakkes.be/en/0628697778/dr-vanderlinden-esther-anatoom-patholoog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Vanderlinden Esther anatoom-patholoog from Wemmel, company number BE0628697778, closed financial year 2025 with a result of € 45,423 after tax. For that financial year Dr. Vanderlinden Esther anatoom-patholoog recorded a gross margin of € 65,135 and equity of € 94,070. Compared with financial year 2024, the result moved from € 9,649 to € 45,423. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Growing

€ 94,070

▲ 93% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 45,423

▲ € 35,775 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 118,979

▲ 53% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 81,670.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 630

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 7,094

▼ 42% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 39,821 Gross margin 2022: € 39,821 First fiscal year in the series	€ 1,794 Gross margin 2023: € 1,794 ▼ 95% vs 2022 (€ 39,821) Unfavourable step	€ -1,663 Gross margin 2024: € -1,663 ▼ € 3,457 vs 2023 (€ 1,794) Unfavourable step	€ 65,135 Gross margin 2025: € 65,135 ▲ € 66,798 vs 2024 (€ -1,663) Favourable step	▲ € 66,798
Profit after taxes	€ 28,030 Profit after taxes 2022: € 28,030 First fiscal year in the series	€ -209 Profit after taxes 2023: € -209 ▼ € 28,239 vs 2022 (€ 28,030) Unfavourable step	€ 9,649 Profit after taxes 2024: € 9,649 ▲ € 9,858 vs 2023 (€ -209) Favourable step	€ 45,423 Profit after taxes 2025: € 45,423 ▲ € 35,775 vs 2024 (€ 9,649) Favourable step	▲ € 35,775
Equity	€ 79,923 Equity 2022: € 79,923 First fiscal year in the series	€ 38,997 Equity 2023: € 38,997 ▼ 51% vs 2022 (€ 79,923) Unfavourable step	€ 48,646 Equity 2024: € 48,646 ▲ 25% vs 2023 (€ 38,997) Favourable step	€ 94,070 Equity 2025: € 94,070 ▲ 93% vs 2024 (€ 48,646) Favourable step	▲ 93%
Total debts	€ 25,643 Total debts 2022: € 25,643 First fiscal year in the series	€ 34,606 Total debts 2023: € 34,606 ▲ 35% vs 2022 (€ 25,643) Unfavourable step	€ 32,687 Total debts 2024: € 32,687 ▼ 6% vs 2023 (€ 34,606) Favourable step	€ 26,778 Total debts 2025: € 26,778 ▼ 18% vs 2024 (€ 32,687) Favourable step	▼ 18%
Cash	€ 74,670 Cash 2022: € 74,670 First fiscal year in the series	€ 62,843 Cash 2023: € 62,843 ▼ 16% vs 2022 (€ 74,670) Unfavourable step	€ 77,847 Cash 2024: € 77,847 ▲ 24% vs 2023 (€ 62,843) Favourable step	€ 118,979 Cash 2025: € 118,979 ▲ 53% vs 2024 (€ 77,847) Favourable step	▲ 53%
Retained profit	€ 67,523 Retained profit 2022: € 67,523 First fiscal year in the series	€ 26,597 Retained profit 2023: € 26,597 ▼ 61% vs 2022 (€ 67,523) Unfavourable step	€ 36,246 Retained profit 2024: € 36,246 ▲ 36% vs 2023 (€ 26,597) Favourable step	€ 81,670 Retained profit 2025: € 81,670 ▲ 125% vs 2024 (€ 36,246) Favourable step	▲ 125%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 40,717 Dividend 2023: € 40,717 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 40,717) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 105,566 Balance sheet total 2022: € 105,566 First fiscal year in the series	€ 73,603 Balance sheet total 2023: € 73,603 ▼ 30% vs 2022 (€ 105,566) Unchanged	€ 81,333 Balance sheet total 2024: € 81,333 ▲ 11% vs 2023 (€ 73,603) Unchanged	€ 120,848 Balance sheet total 2025: € 120,848 ▲ 49% vs 2024 (€ 81,333) Unchanged	▲ 49%

Key figures of Dr. Vanderlinden Esther anatoom-patholoog, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Vanderlinden Esther anatoom-patholoog?

What happened at Dr. Vanderlinden Esther anatoom-patholoog in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: profit of € 45,423 (▲ € 35,775 vs 2024). Source: NBB ↗
Apr 17, 2015 New establishment in Wemmel. KBO
Apr 17, 2015 Start of the company according to the CBE. KBO

In short

From € 28,030 profit in 2022 to € 45,423 profit in 2025.

Paid € 40,327 in corporate taxes since 2022.

Best year ever: 2025, with € 45,423 profit.

Paid out € 40,717 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Vanderlinden Esther anatoom-patholoog? We notify you, reason included.

Follow Dr. Vanderlinden Esther anatoom-patholoog

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Esther Vanderlinden

Dr. Vanderlinden Esther anatoom-patholoog

Behind Dr. Vanderlinden Esther anatoom-patholoog is Esther Vanderlinden.

See the full network in the app

Directors

According to the 2025 annual accounts

Esther Vanderlinden

Manager

Establishments

Establishment units

Physical locations of this company

Registered office

Holland 42

1780 Wemmel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0628.697.778
VAT number: BE 0628.697.778
Registered office: Holland 42, 1780 Wemmel
Names & denominations: Dr. Vanderlinden Esther anatoom-patholoog
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 17 April 2015
Peppol: Active · Active since 12 Jan 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗